The option of liver transplant for unresectable colorectal liver metastases should be considered in a timely manner and not as a last resort.

In the past decade, advanced lung cancer and melanoma have witnessed a surge in Food and Drug Administration (FDA)–approved treatment innovations. Yet, the impact of these advancements on ...

To advance the call to action to optimize dosage of anticancer agents, FDA and ASCO cosponsored two multistakeholder workshops, Getting the Dose Right: Optimizing Dose Selection Strategies in Oncology ...

It was a typical morning in the oncology outpatient clinic. The day was unfolding with its usual cadence. Charts were flipped, the air buzzed with protocol adjustments, and cycles were discussed with ...

PURPOSEPancreatic cancer is one of the most lethal cancers in the United States. Many patients with pancreatic cancer ultimately require end-of-life (EOL) care, which encompasses various aspects, ...

Many seriously ill patients receive much of their care at home from one or more family members. However, shared decision making (SDM)—the collaborative process whereby clinicians and patients work ...

Bladder cancer (BLCA) ranks as the tenth most common malignancy worldwide, with rising incidence and mortality rates. Owing to its molecular and clinical heterogeneity, BLCA is associated with high ...

Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases that are prognostically stratified into lower-risk (LR-MDS) and higher-risk MDS on the basis of the International Prognostic ...

This study investigates the incidence and clinicopathologic characteristics of head and neck cancer (HNC) in the Surinamese population, with an emphasis on the burden of human papillomavirus (HPV) and ...

PURPOSEThere are limited data on the risk for mortality and health outcomes among the increasing population of older (age >50 years) survivors of childhood cancer during this later stage in life ...

Two hundred fifty-one patients were discussed: 137 from Jordan and 114 from eight other countries. Four of the 14 participating oncologists had formal pediatric neuro-oncology training. Of the 227 ...

Human epidermal growth factor receptor 2 (HER2)–positive breast cancer (HER2+BC) is linked to poorer outcomes. Trastuzumab is the standard treatment, but its high cost limits access in ...